Merck & Co., Inc.
MRKDividend Contender • 15yrsAutomated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.
At a glance
Merck & Co., Inc. (MRK) operates in the Drug Manufacturers - General industry and is based in the United States. It pays a quarterly dividend of $3.40 a year, a yield of 2.34% at the current price of $145.27. Merck & Co. has raised its dividend for 15 consecutive years, which makes it a Dividend Contender. Over the last five years the dividend has grown by an average of 6.8% a year. It paid out 267% of its earnings as dividends, more than it earned. 27 analysts cover it; their average 12-month price target of $158.56 is 9.1% above the current price.
Written automatically from the figures on this page, as of Oct 24, 2026. Facts only, not a recommendation.
About Merck & Co., Inc.
Merck & Co. , Inc. operates as a healthcare company worldwide.
Business description sourced from Yahoo Finance / company filings. Not affiliated with SimplyWallStreet.
Key Metrics
Valuation
Profitability
Financial Health
Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.